Brief: Kezar Life Sciences Q1 Net Income USD -16.556 Million
13/05/2025 21:01
May 13 (Reuters) - Kezar Life Sciences Q1 operating expenses USD 17.629 million. Q1 operating income USD -17.629 million
Recent news on Kezar Life Sciences
See all newsNASDAQ TRADE HALT REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 03:28 AM
NASDAQ TRADE HALT TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 03:28 AM
NASDAQ TRADE HALT TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 07:50 PM
U.S. STOCKS ON THE MOVE-Sysco, Crowdstrike, GM